Cardiovascular Clinical Trials 2024

Cardiovascular Clinical Trials 2024

Cardiovascular research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in cardiovascular clinical trials today.

Cardiovascular Clinical Trials

Here are the 6 most popular medical studies for cardiovascular

Popular filter options for cardiovascular trials

Cardiovascular Disease Clinical Trials

View 29 Cardiovascular Disease medical studies.

CVD Clinical Trials

View 29 CVD medical studies.

Phase 3 Cardiovascular Clinical Trials

View 95 phase 3 cardiovascular medical studies.

Cardiovascular Clinical Trials With No Placebo

View 95 cardiovascular medical studies that do not have a placebo group.

View More Cardiovascular Trials

See another 71 medical studies focused on cardiovascular.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to cardiovascular

What are the top hospitals conducting cardiovascular research?

Cutting-edge cardiovascular research is taking place at top hospitals across the United States, paving the way for improved treatments and outcomes for patients with heart conditions. One notable institution leading the charge is the National Institutes of Health Clinical Center in Bethesda. While they currently have four active cardiovascular trials underway, their commitment to advancing cardiac medicine extends beyond specific numbers; it lies in their esteemed reputation as a premier research facility. Similarly, the University of Kansas Medical Center in Kansas City has three ongoing cardiovascular trials that demonstrate their dedication to exploring innovative approaches to heart health.

In Charlottesville, Virginia, the University of Virginia focuses its efforts on cardiovascular research with three active trials and an impressive history of one previously conducted trial dating back to 2021. This young but promising track record demonstrates their commitment to advancing knowledge and treatment options for individuals affected by heart disease.

Meanwhile, Vanderbilt University in Nashville has also emerged as a leader in cardiovascular clinical trials with three ongoing studies aimed at addressing various aspects of cardiac health. Rounding out this list is Excel Medical Clinical Trials located in Boca Raton—a dynamic center contributing significantly through its involvement in three current cardiovascular trials.

These hospitals represent a collective force that strives towards enhancing our understanding of cardiovascular diseases while continually pushing boundaries within medical science and patient care. Their relentless pursuit not only promises new therapeutic breakthroughs but also brings hope to millions around the country living with or impacted by heart-related conditions. Together, these institutions exemplify how collaboration between dedicated researchers and cutting-edge facilities can shape a healthier future for all individuals battling against cardiac ailments

Which are the best cities for cardiovascular clinical trials?

When it comes to cardiovascular clinical trials, several cities emerge as leading hubs for research and development. Boston, Massachusetts is at the forefront with 11 active trials investigating treatments like Olpasiran, reSept ASD Occluder, and Inclisiran. New york, New York follows closely behind with 9 ongoing studies exploring interventions such as Red Blood Cell therapy and BLB Intervention alongside other potential breakthroughs. Las Vegas, Nevada also shows promise with 9 active trials focused on investigational drugs like Orforglipron and Olezarsen. Lastly, Aurora, Colorado and Jacksonville, Florida both exhibit strong involvement in cardiovascular clinical trials with 8 active studies each targeting various treatments for conditions including ASCVD. These cities offer individuals seeking innovative approaches to cardiovascular care access to cutting-edge clinical research that paves the way for advancements in treatment options and potentially improved outcomes.

Which are the top treatments for cardiovascular being explored in clinical trials?

Clinical trials exploring potential treatments for cardiovascular conditions are currently centered around one promising approach: one bout of moderate-intensity sub-maximal aerobic exercise. This innovative method is being tested in a single active trial, which marks the only cardiovascular trial thus far. Its initial listing in 2022 indicates its recent emergence as a frontrunner among researchers seeking novel ways to address cardiovascular health concerns. As scientists delve further into this avenue of exploration, they hope to uncover new insights and possibilities for patients worldwide.

What are the most recent clinical trials for cardiovascular?

Recent clinical trials in the field of cardiovascular research have uncovered promising developments. One notable study focuses on moderate intensity, continuous training (MICT) as a potential intervention for patients with cardiovascular conditions. Another trial examines the efficacy of Orforglipron in treating these ailments, while a separate investigation explores the use of melatonin for cardiovascular health. Additionally, researchers are studying Olpasiran and LY3473329 Dose 1 to assess their impact on people suffering from cardiovascular issues. These innovative trials shed light on potential breakthroughs that could lead to improved treatments and outcomes for individuals with cardiovascular conditions.

What cardiovascular clinical trials were recently completed?

Several significant cardiovascular clinical trials have recently concluded, bringing us closer to advancements in the field of cardiac health. One such trial was completed by Johns Hopkins University in November 2021, exploring a new therapy's effectiveness in reducing heart failure risks. In September 2021, the National Heart, Lung, and Blood Institute wrapped up their trial investigating a novel medication for treating high blood pressure. Additionally, Emory University successfully concluded a trial in January 2021 that examined the impact of lifestyle interventions on preventing heart disease. These groundbreaking studies contribute invaluable insights into cardiovascular care and pave the way for improved treatments and prevention strategies.